Close
Nordic 9Nordic 9

Orphazyme (private company)

Denmark orphazyme.com
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:Biotech
Business model:B2B

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society.

Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 44M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Orphazyme

Name Criteria
United Kingdom Achilles Therapeutics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Belgium Aphea.Bio
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Norway BerGenBio
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark BioPhero
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Enterome
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Top